Genetic Technologies Limited (GENE)
0.7650
0.00 (0.00%)
Inactive · Last trade price on Nov 14, 2024
Genetic Technologies Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Revenue Revenue Growth | 9.67 | 9.67 | 10.35 | 9.22 | 1.33 | 0.84 |
Revenue Growth | -5.57% | -6.52% | 12.25% | 590.65% | 59.30% | 3192.98% |
Gross Profit Gross Profit Growth | 5.91 | 5.91 | 6.01 | 6.2 | 1.16 | 0.74 |
Operating Income Operating Income Growth | -10.59 | -10.59 | -10.42 | -7.54 | -7.42 | -5.94 |
Net Income Net Income Growth | -12.02 | -12.02 | -11.75 | -7.13 | -7.08 | -6.29 |
Earnings Per Share EPS Growth | -0.09 | -0.09 | -0.12 | -0.08 | -0.08 | -0.15 |
EPS Growth | - | - | - | - | - | - |
Revenue by Segment
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Easydna Easydna Growth | 6.16 | 7.7 | 5.99 | - |
Affinitydna Affinitydna Growth | 1.37 | 0.94 | - | - |
Genetype / Corporate Genetype / Corporate Growth | 2.1 | 2.1 | 3.62 | 1.74 |
Total Total Growth | 9.63 | 10.74 | 9.61 | 1.74 |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Cash & Investments Cash & Investments Growth | 1.04 | 1.04 | 7.87 | 11.74 | 20.9 | 14.22 |
Total Debt Total Debt Growth | 0.88 | 0.88 | 0.53 | 0.65 | 0.2 | 0.48 |
Net Cash (Debt) Net Cash Growth | 0.16 | 0.16 | 7.34 | 11.09 | 20.7 | 13.73 |
Net Cash Growth | -95.09% | -97.76% | -33.86% | -46.41% | 50.72% | 528.52% |
Net Cash Per Share Net Cash Per Share Growth | 0.00 | 0.00 | 0.07 | 0.12 | 0.24 | 0.33 |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Operating Cash Flow Operating Cash Flow Growth | -9.68 | -9.68 | -9.72 | -5.66 | -6.3 | -5.71 |
Capital Expenditures CapEx Growth | -0.03 | -0.03 | -0.02 | -0.06 | -0.75 | -0.04 |
Free Cash Flow Free Cash Flow Growth | -9.71 | -9.71 | -9.74 | -5.72 | -7.04 | -5.75 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Gross Margin | 61.12% | 61.12% | 58.10% | 67.31% | 87.23% | 87.89% |
Operating Margin | -109.52% | -109.52% | -100.66% | -81.84% | -556.03% | -708.77% |
Pretax Margin | -124.24% | -124.24% | -115.09% | -77.71% | -530.26% | -751.29% |
Profit Margin | -124.24% | -124.24% | -113.56% | -77.36% | -530.26% | -751.29% |
FCF Margin | -100.41% | -100.41% | -94.13% | -62.09% | -527.79% | -686.29% |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
PS Ratio | - | 1.03 | 2.79 | 3.01 | 57.42 | 44.84 |